Nucleoside transport inhibition for cardioprotection: New perspectives for the clinic
- 1 March 1993
- journal article
- research article
- Published by Wiley in Drug Development Research
- Vol. 28 (3), 344-348
- https://doi.org/10.1002/ddr.430280328
Abstract
No abstract availableKeywords
This publication has 22 references indexed in Scilit:
- Nucleoside transport inhibition: a therapeutic approach to cardioprotection via adenosine?Cardiovascular Research, 1993
- Role of nucleoside transport inhibition and endogenous adenosine in prevention of catecholamine induced death in rabbitsCardiovascular Research, 1993
- Prevention of Catecholamine-Induced Cardiac Damage and Death with a Nucleoside Transport InhibitorJournal of Cardiovascular Pharmacology, 1992
- The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injuryAmerican Heart Journal, 1992
- Comparative Pharmacology of Nucleoside Transport InhibitorsNucleosides and Nucleotides, 1991
- The antifibrillatory effects of R75231, a specific nucleoside transport inhibitorJournal of Molecular and Cellular Cardiology, 1990
- Biochemical and functional effects of nucleoside transport inhibition in the isolated cat heartJournal of Molecular and Cellular Cardiology, 1989
- The cardiac effects of adenosineProgress in Cardiovascular Diseases, 1989
- Changes in creatine phosphate, inorganic phosphate, and the purine pattern in dog hearts with time of coronary artery occlusion and effect thereon of mioflazine, a nucleoside transport inhibitorCardiovascular Research, 1986
- Cardiovascular effects of adenosine in man; possible clinical implicationsProgress in Neurobiology, 1986